Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease

Background: Recent studies have suggested soluble tumor necrotizing factor-like weak inducer of apoptosis (sTWEAK) and sCD163 may be a potential cardiovascular biomarker. We aimed to evaluate sTWEAK and sCD163 levels and predictive values in patients with chronic coronary artery disease (CAD) and ac...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Clin Exp Med
Main Authors: Ilter, Abdulselam, Orem, Cihan, Balaban Yucesan, Fulya, Sahin, Mursel, Hosoglu, Yusuf, Kurumahmutoglu, Elif, Ozer Yaman, Serap, Orem, Asim
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4538003/
https://ncbi.nlm.nih.gov/pubmed/26309601
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares